Jump to main content
Jump to site search

Issue 7, 2015
Previous Article Next Article

Spectropathology for the next generation: Quo vadis?

Author affiliations


Although the potential of vibrational spectroscopy for biomedical applications has been well demonstrated, translation into clinical practice has been relatively slow. This Editorial assesses the challenges facing the field and the potential way forward. While many technological challenges have been addressed to date, considerable effort is still required to gain acceptance of the techniques among the medical community, standardise protocols, extend to a clinically relevant scale, and ultimately assess the health economics underlying clinical deployment. National and international research networks can contribute much to technology development and standardisation. Ultimately, large-scale funding is required to engage in clinical trials and instrument development.

Graphical abstract: Spectropathology for the next generation: Quo vadis?

Back to tab navigation

Publication details

The article was first published on 22 Jan 2015

Article type: Editorial
DOI: 10.1039/C4AN02036G
Author version
Download author version (PDF)
Analyst, 2015,140, 2066-2073

  •   Request permissions

    Spectropathology for the next generation: Quo vadis?

    H. J. Byrne, M. Baranska, G. J. Puppels, N. Stone, B. Wood, K. M. Gough, P. Lasch, P. Heraud, J. Sulé-Suso and G. D. Sockalingum, Analyst, 2015, 140, 2066
    DOI: 10.1039/C4AN02036G

Search articles by author